SCHEMBL9519183

SCHEMBL9519183

O=S(=O)(Nc1ccc(CO)nc1)c1ccc(Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.58
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.50
CYP19A1 P11511 1/20 0.49
PRMT1 Q99873 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
AR P10275 1/20 0.47
WDR5 P61964 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9422522 0.87 MEN1 (0.55) KMT2AALDH1A1MEN1MAPTHTT
SCHEMBL9657786 0.83 CES1 (0.51) CES1KMT2AALDH1A1MEN1KDM4E
SCHEMBL9518021 0.82 LMNA (0.56) ALDH1A1KDM4EMAPTHTTCYP19A1
SCHEMBL9517953 0.82 TRPV1 (0.51) KMT2AMEN1MAPTARHDAC3
SCHEMBL9656899 0.81 TBXAS1 (0.51) CES1KMT2AALDH1A1MEN1KDM4E
SCHEMBL9656313 0.80 TBXAS1 (0.53) CES1KMT2AMEN1KDM4EMAPT
SCHEMBL9519180 0.79 HDAC1 (0.52) ALDH1A1MAPTHDAC3HDAC4HDAC1
SCHEMBL9517896 0.78 AR (0.46) KMT2AALDH1A1MEN1MAPTHTT
SCHEMBL9517930 0.76 PSEN1 (0.54) KMT2ATDP1ARPGR
SCHEMBL2474197 0.76 CES1 (1.00) CES1KMT2AALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed